Cargando…

Developing and Validating a Survival Prediction Model for NSCLC Patients Through Distributed Learning Across 3 Countries

PURPOSE: Tools for survival prediction for non-small cell lung cancer (NSCLC) patients treated with chemoradiation or radiation therapy are of limited quality. In this work, we developed a predictive model of survival at 2 years. The model is based on a large volume of historical patient data and se...

Descripción completa

Detalles Bibliográficos
Autores principales: Jochems, Arthur, Deist, Timo M., El Naqa, Issam, Kessler, Marc, Mayo, Chuck, Reeves, Jackson, Jolly, Shruti, Matuszak, Martha, Ten Haken, Randall, van Soest, Johan, Oberije, Cary, Faivre-Finn, Corinne, Price, Gareth, de Ruysscher, Dirk, Lambin, Philippe, Dekker, Andre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575360/
https://www.ncbi.nlm.nih.gov/pubmed/28871984
http://dx.doi.org/10.1016/j.ijrobp.2017.04.021
Descripción
Sumario:PURPOSE: Tools for survival prediction for non-small cell lung cancer (NSCLC) patients treated with chemoradiation or radiation therapy are of limited quality. In this work, we developed a predictive model of survival at 2 years. The model is based on a large volume of historical patient data and serves as a proof of concept to demonstrate the distributed learning approach. METHODS AND MATERIALS: Clinical data from 698 lung cancer patients, treated with curative intent with chemoradiation or radiation therapy alone, were collected and stored at 2 different cancer institutes (559 patients at Maastro clinic (Netherlands) and 139 at Michigan university [United States]). The model was further validated on 196 patients originating from The Christie (United Kingdon). A Bayesian network model was adapted for distributed learning (the animation can be viewed at https://www.youtube.com/watch?v=ZDJFOxpwqEA). Two-year posttreatment survival was chosen as the endpoint. The Maastro clinic cohort data are publicly available at https://www.cancerdata.org/publication/developing-and-validating-survival-prediction-model-nsclc-patients-through-distributed, and the developed models can be found at www.predictcancer.org. RESULTS: Variables included in the final model were T and N category, age, performance status, and total tumor dose. The model has an area under the curve (AUC) of 0.66 on the external validation set and an AUC of 0.62 on a 5-fold cross validation. A model based on the T and N category performed with an AUC of 0.47 on the validation set, significantly worse than our model (P<.001). Learning the model in a centralized or distributed fashion yields a minor difference on the probabilities of the conditional probability tables (0.6%); the discriminative performance of the models on the validation set is similar (P=.26). CONCLUSIONS: Distributed learning from federated databases allows learning of predictive models on data originating from multiple institutions while avoiding many of the data-sharing barriers. We believe that distributed learning is the future of sharing data in health care.